A Detailed Analysis of the Drug Discovery Enzymes Market Based on the Rising Demand for Innovative Solutions in Pharmaceutical Drug Discovery
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 115
Report ID: PMRREP33955
1. Executive Summary
1.1. Global Drug Discovery Enzymes Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. System Location Lifecycle Analysis
2.4. Drug Discovery Enzymes Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Drug Discovery Enzymes Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Drug Discovery Enzymes Market Outlook: Product Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
3.3.3.1. Active Kinases
3.3.3.2. Ubiquitin
3.3.3.3. Epigenetic
3.3.3.4. Methyltransferases
3.3.3.5. Deacetylases
3.3.3.6. Phosphodiesterases
3.3.3.7. Other Product Types
3.4. Market Attractiveness Analysis: Product Type
3.5. Global Drug Discovery Enzymes Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.5.3.1. Pharmaceutical and Biotechnology Company
3.5.3.2. Research institutes
3.5.3.3. Other end user
3.6. Market Attractiveness Analysis: End User
4. Global Drug Discovery Enzymes Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Drug Discovery Enzymes Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product Type
5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
5.5.1. Active Kinases
5.5.2. Ubiquitin
5.5.3. Epigenetic
5.5.4. Methyltransferases
5.5.5. Deacetylases
5.5.6. Phosphodiesterases
5.5.7. Other Product Types
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.6.1. Pharmaceutical and Biotechnology Company
5.6.2. Research institutes
5.6.3. Other end user
5.7. Market Attractiveness Analysis
6. Europe Drug Discovery Enzymes Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product Type
6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. T rkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
6.5.1. Active Kinases
6.5.2. Ubiquitin
6.5.3. Epigenetic
6.5.4. Methyltransferases
6.5.5. Deacetylases
6.5.6. Phosphodiesterases
6.5.7. Other Product Types
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.6.1. Pharmaceutical and Biotechnology Company
6.6.2. Research institutes
6.6.3. Other end user
6.7. Market Attractiveness Analysis
7. East Asia Drug Discovery Enzymes Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product Type
7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
7.5.1. Active Kinases
7.5.2. Ubiquitin
7.5.3. Epigenetic
7.5.4. Methyltransferases
7.5.5. Deacetylases
7.5.6. Phosphodiesterases
7.5.7. Other Product Types
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.6.1. Pharmaceutical and Biotechnology Company
7.6.2. Research institutes
7.6.3. Other end user
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Drug Discovery Enzymes Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
8.5.1. Active Kinases
8.5.2. Ubiquitin
8.5.3. Epigenetic
8.5.4. Methyltransferases
8.5.5. Deacetylases
8.5.6. Phosphodiesterases
8.5.7. Other Product Types
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.6.1. Pharmaceutical and Biotechnology Company
8.6.2. Research institutes
8.6.3. Other end user
8.7. Market Attractiveness Analysis
9. Latin America Drug Discovery Enzymes Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
9.5.1. Active Kinases
9.5.2. Ubiquitin
9.5.3. Epigenetic
9.5.4. Methyltransferases
9.5.5. Deacetylases
9.5.6. Phosphodiesterases
9.5.7. Other Product Types
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.6.1. Pharmaceutical and Biotechnology Company
9.6.2. Research institutes
9.6.3. Other end user
9.7. Market Attractiveness Analysis
10. Middle East & Africa Drug Discovery Enzymes Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
10.5.1. Active Kinases
10.5.2. Ubiquitin
10.5.3. Epigenetic
10.5.4. Methyltransferases
10.5.5. Deacetylases
10.5.6. Phosphodiesterases
10.5.7. Other Product Types
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.6.1. Pharmaceutical and Biotechnology Company
10.6.2. Research institutes
10.6.3. Other end user
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Sigma-Aldrich Co. LLC.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Kaneka Corporation
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Actelion Pharmaceuticals Ltd
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Genesis Biotechnology Group
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Suven Life Sciences Limited
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Enzo Life Sciences, Inc.
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Merck KGaA
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Apeiron Biologics
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. STORM Therapeutics
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Thermo Fisher Scientific
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Abcam
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
